Mergers & Acquisitions Mergers & Acquisitions

J&J-TachoSil deal headed for in-depth EU investigation

By Natalie McNelis
  • 25 Mar 2020 05:02
  • 25 Mar 2020 05:09

Johnson & Johnson’s purchase of the TachoSil surgical-patch business from Japan's Takeda Pharmaceutical is headed for an in-depth EU investigation, MLex has learned.

That would put the European Commission’s deadline to decide on the deal in August.

TachoSil is a surgical patch used to control bleeding in cardiovascular and liver

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News